Aligned Genetics Inc, formerly Logos Biosystems Inc, is a Korea-based company engaged in the manufacture and sale of medical equipment. The Company's products mainly consist of automated cell counters, such as LUNA, LUNA-FL, LUNA-STEM, LUNA-II, LUNA- YF, QUANTOM, tissue clearing systems, such as X-CLARITY, and digital cell imaging systems, such as iRiS.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
26-06-11	3,190.00 ₩	-3.77%	15,673
26-06-11	3,315.00 ₩	+4.57%	5,734
26-06-10	3,170.00 ₩	-1.55%	11,120
26-06-09	3,220.00 ₩	+0.47%	39,391
26-06-08	3,205.00 ₩	-5.74%	30,941

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 2026-06-12			5-day change	1st Jan Change
3,190.00 ^KRW	-3.77%		-9.12%	-17.57%

11-14	ACS, BlackRock launch 2 billion euro data centre joint venture	RE
11-13	ACS, BlackRock to seal $27 billion data centre deal, report says	RE

Market Cap	44.85B 29.31M 25.43M 23.44M 21.97M 41.04M 2.81B 41.9M 280M 108M 1.35B 110M 108M 4.7B	P/E Ratio 2024	10.5x	P/E Ratio 2025	18.8x
Enterprise Value	44.73B 29.23M 25.37M 23.38M 21.91M 40.94M 2.8B 41.79M 279M 108M 1.35B 110M 107M 4.69B	EV / Sales 2024	1.83x	EV / Sales 2025	3.39x
Free-Float	57.99%	Yield 2024 *	-	Yield 2025	-

11-14	ACS, BlackRock launch 2 billion euro data centre joint venture	RE
11-13	ACS, BlackRock to seal $27 billion data centre deal, report says	RE
25-10-16	Macquarie confident in AI, data centre future after $40 billion Aligned sale	RE
25-09-12	Aligned Genetics Inc to acquire real estate worth 14 billion won	RE
25-07-21	Aligned Genetics, Inc.'s Equity Buyback announced on January 21, 2025 has with 320,622 shares, representing 2.24% for KRW 997.53 million.	CI
25-07-21	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
25-07-21	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
25-04-24	Tranche Update on Aligned Genetics, Inc.'s Equity Buyback Plan announced on January 21, 2025.	CI
25-01-21	Aligned Genetics, Inc. announces an Equity Buyback for KRW 1,000 million worth of its shares.	CI
25-01-20	Aligned Genetics, Inc. authorizes a Buyback Plan.	CI
16-11-01	Logos Biosystems, Inc. has completed an IPO in the amount of KRW 18.056448 billion.	CI
16-06-16	Logos Biosystems, Inc. has filed an IPO.	CI

11-14	ACS y BlackRock lanzan una empresa conjunta de centros de datos por valor de 2.000 millones de euros
11-13	ACS y BlackRock cerrarán un acuerdo de centros de datos por 27.000 millones de dólares, según medio

Aligned Genetics, Inc. Stock

Stocks

A238120

KR7238120000

Advanced Medical Equipment & Technology

Valuation: Aligned Genetics, Inc.

Chart: Aligned Genetics, Inc.

Latest news : Aligned Genetics, Inc.

News in other languages: Aligned Genetics, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Aligned Genetics, Inc.

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

1 day	-3.77%
1 week	-9.12%
Current month	-13.78%
1 month	-23.23%
3 months	-27.83%
6 months	-18.83%
Current year	-17.57%

1 week	2,935	3,430
1 month	2,935	4,395
Current year	2,935	6,050
1 year	2,935	6,050
3 years	2,575	6,175
5 years	2,575	6,925
10 years	2,002.5	9,150

Manager	Title	Age	Since
Yun-chul Jung CEO	Chief Executive Officer	56	2008-09-30
Yeon-suk Jung PRN	Corporate Officer/Principal	53	2012-02-29
Keun-chang Cho PRN	Corporate Officer/Principal	58	2008-09-30

Director	Title	Age	Since
Keun-chang Cho BRD	Director/Board Member	58	2008-09-30
Yun-chul Jung BRD	Director/Board Member	56	2008-09-30
Yeon-suk Jung BRD	Director/Board Member	53	2012-02-29

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ALIGNED GENETICS, INC.	-3.77%	-9.12%	-7.80%	-26.07%	30.45M
SARTORIUS AG	+0.35%	-2.32%	+11.21%	-31.46%	16.47B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-0.23%	-2.76%	+28.35%	+60.46%	1.67B
ECKERT & ZIEGLER SE	-0.65%	-0.90%	-31.26%	+17.62%	1.11B
QUIDELORTHO CORPORATION	+0.67%	-1.01%	-52.53%	-83.15%	961M
CONTEC MEDICAL SYSTEMS CO.,LTD	+2.05%	-2.32%	-23.41%	-54.31%	635M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	+1.38%	-1.41%	-46.80%	-59.08%	561M
VAREX IMAGING CORPORATION	+3.13%	+13.38%	+34.11%	-50.04%	465M
REVENIO GROUP OYJ	-1.57%	-4.56%	-54.98%	-62.49%	391M
TOMOCUBE, INC.	-2.34%	-10.69%	+44.34%	-	337M
Average	-0.01%	+0.18%	-9.88%	-32.06%	2.26B
Weighted average by Cap.	+0.85%	-5.25%	+5.06%	-26.64%

	2024	2025
Net sales	15.78B 10.31M 8.95M 8.25M 7.73M 14.44M 987M 14.74M 98.38M 38.09M 476M 38.71M 37.87M 1.65B	16.02B 10.47M 9.08M 8.37M 7.84M 14.66M 1B 14.96M 99.87M 38.67M 483M 39.29M 38.44M 1.68B
Net income	4.13B 2.7M 2.34M 2.16M 2.02M 3.78M 258M 3.86M 25.74M 9.97M 125M 10.13M 9.91M 433M	2.91B 1.9M 1.65M 1.52M 1.43M 2.66M 182M 2.72M 18.15M 7.03M 87.81M 7.14M 6.99M 305M
Net Debt	-14.68B -9.59M -8.32M -7.67M -7.19M -13.43M -918M -13.71M -91.51M -35.43M -443M -36M -35.23M -1.54B	-113M -73.85K -64.09K -59.08K -55.35K -103K -7.07M -106K -705K -273K -3.41M -277K -271K -11.85M